Latest news
Standard BioTools Sells Mass Cytometry Business and Secures $30 Million Illumina Buyout Ahead of Treeline Merger - citybiz.cocitybiz.co · Tue, 28 Jul 2026 12:32:40 GMTStandard BioTools (NASDAQ: LAB) nets $30M Illumina buyout, sells mass cytometry arm - Stock TitanStock Titan · Tue, 28 Jul 2026 12:25:42 GMTStandard BioTools (LAB) plans sale of Mass Cytometry business alongside Treeline deal - Stock TitanStock Titan · Tue, 28 Jul 2026 07:00:00 GMTStandard BioTools Announces Sale of Mass Cytometry Business and Illumina’s Buyout of Contingent Payments to Advance Merger with Treeline Biosciences - SahmSahm · Tue, 28 Jul 2026 07:00:00 GMTStandard BioTools sells Mass Cytometry business and secures $30M from Illumina earnout buyout - PluangPluang · Tue, 28 Jul 2026 07:00:00 GMTMultiplex BioTech Private Limited agreed to acquire Mass Cytometry Business of Standard BioTools Inc. (NasdaqGS : LAB) for $10 million. - marketscreener.commarketscreener.com · Mon, 27 Jul 2026 07:00:00 GMT